Bayani
Tsarin kwayoyin halitta na wannan matsakaici shine C13H10ClN3O2S, kuma nauyin kwayoyinsa shine 307.755.Madaidaicin tsarin kwayoyin sa yana ba da damar samar da inganci da tsaftar tofacitinib.Saboda haka, tofacitinib tsaka-tsakin 1,4-chloro-7-p-toluenesulfonyl-7H pyrrolo [2,3-d] pyrimidine wani muhimmin sashi ne a cikin masana'antun magunguna don samar da magani mai mahimmanci ga cututtuka na autoimmune.
Ana ƙera samfuranmu ta amfani da hanyoyin zamani don tabbatar da mafi girman inganci da daidaito.Mun fahimci mahimmancin samun amintattun masu tsattsauran ra'ayi a cikin samar da magunguna, wanda shine dalilin da ya sa muka himmatu wajen kiyaye ƙaƙƙarfan ƙa'idodi yayin aikin masana'antar mu.Mu tofacitinib tsaka-tsakin 1,4-chloro-7-p-toluenesulfonyl-7H pyrrolo [2,3-d] pyrimidine yana fuskantar tsattsauran tsafta, kwanciyar hankali da gwajin aminci don ba da damar abokan cinikinmu Amincewa da amincin babban sikelin kira na tofacitinib.
Zaba Mu
JDK ya mallaki wuraren samar da ajin farko da na'urorin sarrafa inganci, wanda ke ba da tabbacin samar da tsayayyen samar da matsakaicin API.Ƙwararrun ƙungiyar sun tabbatar da R&D na samfurin.A kan duka biyun, muna neman CMO & CDMO a cikin gida da kasuwannin duniya.